Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AGAMREE ®safely and effectively. See full prescribing information for AGAMREE. AGAMREE (vamorolone) oral suspension Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
AGAMREE is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- vamorolone
- product_names
- VAMOROLONE
- ndc
- 69616-264, 69616-265, 69616-264-38, 69616-265-38
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en